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Abstract 
The basolateral K+ channel KCNJ10 (Kir4.1), is expressed in the renal distal convoluted 
tubule (DCT) and controls the activity of the thiazide-sensitive NaCl cotransporter 
(NCC). Loss-of-function mutations of KCNJ10 cause EAST/SeSAME syndrome with 
salt wasting and severe hypokalemia. KCNJ10 is also expressed in the principal cells 
of the collecting system (CS); however, its pathophysiological role in this segment has 
not been studied in detail. To address this question, we generated the mouse model 
AQP2cre:Kcnj10flox/flox with a deletion of Kcnj10 specifically in the CS (CS-Kcnj10-KO). 
CS-Kcnj10-KO mice responded normally to standard and high K+ diet. However, CS-
Kcnj10-KO exhibited a higher kaliuresis and lower plasma K+ than control mice when 
treated with thiazide diuretics. Likewise, CS-Kcnj10-KO displayed an inadequately 
high kaliuresis and renal Na+ retention upon dietary K+ restriction. In this condition, 
CS-Kcnj10-KO mice became hypokalemic due to an insufficient downregulation of the 
epithelial Na+ channel (ENaC) and the renal outer medullary K+ channel (ROMK) in 
the CS. Consistently, the phenotype of CS-Kcnj10-KO was fully abrogated by ENaC 
inhibition with amiloride and ameliorated by genetic inactivation of ROMK in the CS. 
In conclusion, KCNJ10 in the CS contributes to the renal control of K+ homeostasis by 
regulating ENaC and ROMK. Impaired KCNJ10 function in the CS predisposes for 
thiazide- and low K+ diet-induced hypokalemia and likely contributes to the 
pathophysiology of renal K+ loss in EAST/SeSAME syndrome. 
Keywords: 
Potassium homeostasis, diuretics, dietary potassium, collecting duct, connecting 
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Translational Statement 
The regulation of renal K+ excretion is crucial for K+ homeostasis and hence, the proper 
function of excitable cells. The present study shows that the basolateral K+ channel 
Kir4.1 (encoded by KCNJ10) acts as a local K+ sensor in the collecting system. Kir4.1 
contributes to the aldosterone-independent adaptation of ENaC and ROMK function 
and hence, K+ excretion. Mutations and/or polymorphisms of KCNJ10 may contribute 
to disturbances in K+ balance.  
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Introduction 
EAST/SeSAME syndrome is caused by loss-of-function mutations of the inwardly 
rectifying K+ channel Kir4.1 encoded by the KCNJ10 gene1,2. This syndrome is 
characterized by epilepsy, ataxia, sensorineural deafness and a renal salt wasting 
tubulopathy with severe hypokalemia. In the kidney, KCNJ10 is expressed in the 
basolateral membrane of the cortical thick ascending limb (TAL), the distal convoluted 
tubule (DCT) and the principal cells of the collecting system (CS) including the 
connecting tubule (CNT) and the collecting duct (CD)3. Kir4.1 may form heterotetramers 
with Kir5.1 (encoded by the Kcnj16 gene), which then set the basolateral membrane 
voltage of DCT cells4. While Kir5.1 alone does not conduct measurable K+ currents5, 
Kir4.1 functions not only as Kir4.1/Kir5.1 heterotetramers but also as Kir4.1 
homotetramers. It is generally accepted that the renal phenotype in EAST/SeSAME 
syndrome is a consequence of the defective function of Kir4.1 in the DCT, where 
KCNJ10 expression is at highest levels6. Indeed, EAST/SeSAME patients show a 
renal phenotype that mimics the one seen in patients with Gitelman syndrome who 
have loss-of-function mutations of the DCT-specific thiazide-sensitive NaCl 
cotransporter (NCC)1,7. Likewise, Kcnj10 knockout mice show a diminished activity of 
NCC8. 
Kir4.1 is thought to interfere with NCC regulation via a complex signaling mechanism 
that involves the with no lysine kinase WNK4, the STE20/SPS1-related, proline 
alanine-rich kinase (SPAK) and the oxidative stress responsive kinase 1 (OSR1). Loss 
of Kir4.1 diminishes the plasma membrane voltage of DCT cells, which reduces Cl- 
efflux via the basolateral chloride channel ClC-Kb. The subsequently increased 
intracellular Cl- concentration inhibits WNK4 and hence reduces SPAK/OSR1-
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mediated NCC phosphorylation and activity9. The WNK4/SPAK/OSR1 signaling 
pathway also mediates the K+ sensitivity of the DCT10. Low K+ increases NCC 
phosphorylation, while high K+ rapidly decreases NCC phosphorylation11,12 via a 
mechanism that depends on the expression of Kir4.113. 
According to the current concept, K+-dependent downregulation of NCC increases Na+ 
delivery to the CS. In the CS, Na+ reabsorption via the epithelial Na+ channel (ENaC) 
promotes kaliuresis by enhancing the driving force for K+ excretion via the renal outer 
medullary K+ channel (ROMK) and other K+ channels14. High plasma K+ also 
stimulates the production of aldosterone by the adrenal gland, which activates ENaC 
and ROMK in the CS and hence enhances kaliuresis15. The combination of NCC 
inhibition in the DCT with the subsequent aldosterone-dependent activation of Na+ 
reabsorption and K+ secretion in the CS is thought to explain the kaliuresis and 
hypokalemia observed in patients with genetic (EAST/SeSAME1 and Gitelman16 
syndromes) or pharmacological (thiazide and thiazide-like diuretics17) inactivation of 
NCC.  
Nevertheless, other studies already stressed that NCC inactivation alone is not 
sufficient to enhance renal K+ secretion and thus cannot solely explain the kaliuresis 
upon a high K+ intake18. Likewise, K+ secretion and activation of ENaC and ROMK in 
response to dietary K+ can occur independent from aldosterone19–21. Interestingly, in 
vivo data suggests that the CS directly responds to altered plasma K+22. Moreover, 
previous genetic23 and pharmacological24 studies indicated that Kir4.1 participates also 
in setting the membrane potential of principal cells in the CS. Therefore, we 
hypothesized that Kir4.1 may act as a local K+ sensor in the CS to mediate the 
adaptation of ENaC and ROMK to dietary K+. Loss of Kir4.1 in the CS could lead to a 
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maladaptation of ENaC and ROMK and contribute to the hypokalemia in 
EAST/SeSAME patients. 
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Results 
CS-Kcnj10-KO mice do not exhibit any evident clinical phenotype 
under standard conditions. 
To investigate the function of Kir4.1 in the CNT and CD, collecting system (CS)-specific 
Kcnj10-KO mice (CS-Kcnj10-KO) were generated by breeding mice with ´floxed´ 
Kcnj10 alleles (Kcnj10flox/flox) with mice expressing the Cre recombinase under the 
control of the Aqp2 promoter (Aqp2cre). CS-Kcnj10-KO mice were born in a Mendelian 
ratio and thrived normally. Immunofluorescence staining of consecutive kidney 
sections with antibodies against AQP2, Kir4.1 and NCC confirmed that control mice 
express Kir4.1 in both NCC-positive DCTs and AQP2-positive CS. In CS-Kcnj10-KO 
mice, the expression of Kir4.1 in DCTs was unaffected, while it was completely absent 
in the CS (Figs. 1 A and B). Under standard diet, the plasma parameters of CS-Kcnj10-
KO mice were similar to those of control mice (Table 1). Consistent with a normal Na+ 
and K+ balance under control conditions, renal renin mRNA and plasma aldosterone 
concentration were similar in control and CS-Kcnj10-KO mice (Fig. 1C). Furthermore, 
abundances and post-translational modifications (cleavage, glycosylation and 
phosphorylation) of channels and transporters in the renal tubule (e.g. NCC, ENaC, 
ROMK, Na+/K+ - ATPase and AQP2) were similar in both genotypes (Figs. 1 D and E).  
 
The potassium sensitivity of the DCT is preserved in CS-Kcnj10-KO 
mice. 
An acute rise of plasma or extracellular K+ promotes a rapid dephosphorylation of NCC 
11,12,10,25, which is thought to depend on Kcnj1026. To test if K+-dependent regulation 
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of NCC in CS-Kcnj10-KO mice is affected, kidney slices were incubated ex vivo with 
different extracellular K+ concentrations. As shown in Figs. 2 A and B, a high 
extracellular K+ concentration decreased while a low extracellular K+ concentration 
increased NCC phosphorylation in similar ways in both genotypes. In kidney slices 
from CS-Kcnj10-KO incubated with 3-5 mmol/L of K+, the phosphorylation of NCC was 
slightly increased. The cause of this slight difference is unclear; nevertheless, CS-
Kcnj10-KO and control animals exhibited similar plasma K+ and NCC phosphorylation 
levels in vivo under standard diet (Fig. 1D). Moreover, the inverse correlation between 
NCC phosphorylation and plasma K+ concentration was similar for control and CS-
Kcnj10-KO mice (Supplementary figure 1).  
CS-Kcnj10-KO mice are prone to develop thiazide-induced 
hypokalemia. 
Loss of function of Kir4.1 causes hypokalemia in patients with EAST/SeSAME 
syndrome and in Kcnj10-KO mouse models1,13 and is thought to be related to a 
malfunction of the DCT6,8,13. In line with this hypothesis, CS-Kcnj10-KO mice are not 
hypokalemic under standard conditions. When treated with HCTZ, control and CS-
Kcnj10-KO mice exhibited a similar natriuresis (Fig. 3 A and B), consistent with similar 
NCC abundances in both genotypes. Compared to the time d0 (before thiazide-
treatment), control animals did not display a significant HCTZ-induced kaliuresis as 
previously described18 (Fig. 3 A and B). On the contrary, CS-Kcnj10-KO animals 
exhibited an increased kaliuresis and urinary K+/Na+ ratio, (Fig. 3 A and B). 
Consequently, after three days of continuous thiazide-treatment, CS-Kcnj10-KO had 
significantly lower plasma K+ concentrations than control mice and developed 
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hypochloremic metabolic alkalosis and hyponatremia (Table 2), recapitulating the 
main symptoms observed in EAST/SeSAME patients.  
CS-Kcnj10-KO mice develop severe hypokalemia upon dietary K+ 
restriction.  
Mouse neonates with a global Kcnj10 deletion have depolarized principal cells in the 
CS and an increased ENaC expression despite of hypokalemia23. Now, we tested 
whether the lack of Kir4.1 in the CS directly stimulates ENaC and activates K+ excretion. 
To test this hypothesis, CS-Kcnj10-KO and control mice were fed a low K+ diet 
(<0.05% K+) for three days and urinary and plasma parameters were assessed. 
While control animals immediately started losing Na+, CS-Kcnj10-KO mice retained 
Na+ under low dietary K+ conditions (Fig. 4A). Moreover, after the second day on a low 
K+ diet, CS-Kcnj10-KO mice exhibited an inappropriately high kaliuresis compared to 
control animals. Consequently, CS-Kcnj10-KO mice developed severe hypokalemia 
and hypochloremia (Table 3). In contrast to the maladaptation on low K+ diet, CS-
Kcnj10-KO mice adapted normally to a dietary K+ load (Fig. 4B). (Table 4).  
 
CS-Kcnj10-KO mice fail to inactivate ENaC when fed a low K+ diet.  
Next, we studied the abundance of distal tubule ion channels and transporters in 
control and CS-Kcnj10-KO mice subjected to dietary K+ deprivation. As shown in Fig. 
5A and B, NCC phosphorylation was significantly increased in CS-Kcnj10-KO 
compared to control mice, likely reflecting the more severe hypokalemia of CS-Kcnj10-
KO. Moreover, -ENaC cleavage was significantly augmented in CS-Kcnj10-KO 
despite the severe hypokalemia.  
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To study the expression and localization of ENaC at the tubular level, we performed 
immunofluorescence stainings on kidneys from control and CS-Kcnj10-KO mice after 
3 days of dietary K+ deprivation. As shown in Fig. 5C, the apical localization of ENaC 
was increased in AQP2-positive CS of CS-Kcnj10-KO mice compared to control 
animals. To evaluate the functional significance of the inappropriate high apical  ENaC 
abundance in the CS of CS-Kcnj10-KO mice, CS-Kcnj10-KO and control animals were 
kept on a low K+ diet for two days in metabolic cages. Afterwards, a single i.p. injection 
of the ENaC inhibitor amiloride was administered and urine was collected for the next 
4h. Consistent with a low K+ diet-induced ENaC inactivation, control mice did not 
reveal a significant natriuresis and kaliuresis in response to amiloride. In contrast, CS-
Kcnj10-KO mice showed a pronounced amiloride-induced natriuresis and kaliuresis 
(Fig. 5D).  
CS-Kcnj10-KO mice fail to inactivate ROMK when fed a low K+ diet. 
As shown in Fig. 1D and Fig. 5A, the expression and glycosylation of ROMK in the 
whole kidney was unchanged in CS-Kcnj10-KO mice compared to control mice. 
However, ROMK is not only expressed in the CS, but highly abundant in the thick 
ascending limb (TAL) and in the DCT27 which could mask subtle changes in the 
abundance of ROMK in the CS. To study the expression and localization of ROMK 
specifically in the CS, we performed immunofluorescent studies on consecutive 
sections of kidneys from control and CS-Kcnj10-KO mice upon 3 days of dietary K+ 
deprivation. As shown in Fig. 6A, the abundance of ROMK in the AQP2-positive CS 
of control animals was very weak compared to the AQP2-negative TAL cells. However, 
in the CS-Kcnj10-KO mice, ROMK abundance was profoundly increased in the apical 
region of the principal cells in the CS cells and reached a staining intensity quite similar 
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to the one seen in the TAL cells. Quantification of ROMK staining intensities across 
the axis (basal to apical) of CS cells from control and CS-Kcnj10-KO confirmed the 
visual observations (Fig. 6A).  
To assess the contribution of the inappropriate regulation of ROMK to the phenotype 
of CS-Kcnj10-KO mice, Kcnj1 (ROMK) was genetically ablated in the CS of CS-
Kcnj10-KO mice. To this end, CS-Kcnj10-KO mice were crossed with a newly 
developed Kcnj1flox/flox mouse line to obtain a CS-specific Kcnj10 and ROMK double-
KO (CS-Kcnj10-ROMK-KO) (Supplementary Figure 2). Apart from a mild 
hypercalciuria, the CS-Kcnj10-ROMK-KO mice were normal under control conditions 
(Supplementary Table 1). When subjected to a low K+ diet for 3 days, the CS-Kcnj10-
ROMK-KO were protected from the severe hypokalemia observed in CS-Kcnj10-KO 
mice and had plasma K+ levels in the range of control mice (Fig. 6B and Table 5). 
Consistent with the measured plasma K+ levels, the renal K+ loss of CS-Kcnj10-
ROMK-KO mice on day 2 of dietary K+ deprivation was significantly lower than the one 
seen in CS-Kcnj10-KO mice (21.0 ± 2.2 (n=9) vs. 54.3 ± 6.5 (n=6); p<0.0001; unpaired 
Students t-test). Nevertheless, despite the deletion of ROMK, CS-Kcnj10-ROMK-KO 
mice excreted significantly more K+ in the urine than control animals (Fig. 6C, open 
circles). Interestingly, ENaC inhibiton by amiloride significantly reduced urinary K+ 
excretion, but had little effect on urinary Na+ excretion in CS-Kcnj10-ROMK-KO mice. 
The reason for the reduced amiloride response in double KO mice compared with the 
single CS-Kcnj10-KO mice is unclear, but may indicate that the loss of ROMK affects 
also ENaC activity. Future studies will have to address this intriguing possibility.  
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Discussion 
EAST/SeSAME patients suffer from loss-of-function mutations of KCNJ10 in the DCT 
and display severe hypokalemia and a renal tubulopathy that is reminiscent of 
Gitelman’s syndrome1–3. These observations led to the current concept that the renal 
phenotype of patients with loss-of-function mutations in KCNJ10 is mainly due to an 
impaired DCT function3. According to this concept, the reduced NCC activity in 
patients with EAST/SeSAME syndrome results in an increased NaCl delivery to the 
CS. The concomitant enhanced Na+ reabsorption in the principal cells of the CS via 
ENaC leads to an increased K+ secretion via ROMK resulting in hypokalemia. This 
situation is further aggravated by an activation of the renin-angiotensin-aldosterone 
and the concurrent enhancement of ENaC function. In fact, mouse models with global 
or kidney-specific deletion of Kcnj10 showed a strong downregulation of NCC8,13 and 
an up-regulation of ENaC23, which is thought to explain the severe hypokalemia 
observed in these mice. Now, we used a mouse model with a targeted deletion of 
Kcnj10 specifically in the principal cells of the CS to test the hypothesis that KCNJ10 
participates to the direct regulation of ENaC and ROMK and that a lack of KCNJ10 in 
the CS contributes to the hypokalemia.  
In contrast to total or kidney-specific Kcnj10-KO mice, CS-Kcnj10-KO mice had an 
intact DCT function and did not show an apparent phenotype under control conditions. 
The DCT of CS-Kcnj10-KO mice exhibited a preserved sensitivity to changes in 
extracellular K+ as evidenced by the K+-dependency of NCC phosphorylation in vivo 
and ex vivo. Moreover, CS-Kcnj10-KO mice revealed a normal adaptation to increased 
dietary intake of K+. However, when placed on a low K+ diet, the CS-Kcnj10-KO mice 
became severely hypokalemic. Likewise, CS-Kcnj10-KO mice developed hypokalemia 
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and hypochloremic metabolic alkalosis when treated with the NCC inhibitor HCTZ, 
recapitulating the main renal symptoms of EAST/SeSAME syndrome1. These findings 
support the idea that the renal phenotype in EAST/SeSAME syndrome results from 
the combined defect of NCC regulation in the DCT and ENaC and ROMK regulation 
in the CS.  
The secretion of K+ in the CS is thought to be mediated via an aldosterone-dependent 
upregulation of ENaC28,29 and the activation of ROMK27 and the large K+ conductance 
(BK) potassium channels30,31. In addition, an aldosterone-independent control of renal 
K+ secretion was suggested32, which might involve a kaliuretic factor 33 34. However, 
the nature and identity of this kaliuretic factor remains elusive. Recently, Kir4.1, in 
combination with Kir5.124, was proposed to act as a K+ sensor in the DCT13 that directly 
mediates the regulation of NCC activity via dietary K+26 and Na+35. Now, our data 
suggest that Kir4.1 does also act as a local K+ sensor in the CS and directly adapts the 
K+ secretion of the CS to altered extracellular K+ concentrations. Interestingly, also 
Dahl salt-sensitive rats deficient for Kcnj16 (SSKcnj16-/-) develop severe, life-threatening 
hypokalemia when placed on a high NaCl diet36. The phenotype was rescued by the 
ENaC inhibitor benzamil suggesting that Kir5.1 also participates to the direct adaptation 
of ENaC function to altered dietary ion intakes.  
Previous studies indicated that the activity of ENaC and ROMK in the CS correlates 
with the extent of the proteolytic cleavage of the ENaC subunits37 and their apical 
localization27. Our immunoblot data on kidney lysates together with our 
immunofluorescence studies indicate that the CS-Kcnj10-KO have an inappropriately 
high ENaC and ROMK activity on a low K+ diet, which likely explains the renal K+ loss 
and severe hypokalemia seen in these mice. Consistent with this idea and in 
agreement with the experiments by Palygin and coworkers in SSKcnj16-/- rats36, the 
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pharmacological inhibition of ENaC by amiloride fully abrogated the urinary K+ loss in 
CS-Kcnj10-KO mice. Moreover, the genetic inactivation of ROMK significantly 
mitigated the renal K+ loss. However, we observed a slight, but persistent renal loss 
of K+ in CS-Kcnj10-ROMK-KO suggesting that additional K+ channels (e.g. BK) 
contribute to the inappropriately high K+ secretion of CS-Kcnj10-KO mice on a low K+ 
diet. Indeed, previous studies suggested that both ROMK and BK contribute to renal 
K+ excretion and that each channel can compensate for the lack of the other one38. 
Thus, our data indicate that Kcnj10 contributes to the direct K+-dependent regulation 
of ENaC, ROMK and probably other K+ channels in the CS. As such, our data are 
compatible with previous studies suggesting that dietary K+ directly regulates the 
activity of ENaC and ROMK20,22,39, which occurs independent from aldosterone21. 
While Kir4.1 regulates NCC activity via WNK/SPAK pathway13, the molecular 
mechanisms mediating the regulation of ENaC and ROMK expression in the CS are 
unclear. The kidney-specific WNK1 (KS-WNK1)40 and the mTORC241 pathway were 
implicated in the regulation of ROMK and in the control of renal K+ excretion. Likewise, 
the serum- and glucocorticoid-induced kinase 1 (SGK1), and the glucocorticoid-
induced leucine zipper protein (GILZ1) were suggested to synergistically control ENaC 
cell surface expression and activity42. While this manuscript was submitted, Sorensen 
and coworkers reported that extracellular K+ directly stimulates the mTORC2-
dependent phosphorylation of SGK1 in cultured CCD cells which activates ENaC and 
hence favors K+ secretion43. Pharmacological inhibition of Kir4.1 with the inhibitor 
VU013499244 blocked the activation of mTORC2 and ENaC suggesting an 
involvement of Kir4.1 in the K+-dependent regulation of ENaC. Using a genetic 
approach, our current study demonstrates that Kir4.1 is indeed critical for a proper 
downregulation of both ENaC and ROMK in response to a low K+ diet in vivo.  
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In summary, our data demonstrate that the Kir4.1 in the CS is indispensable for the 
proper renal adaptation to dietary K+ depletion and modulates the response to thiazide 
diuretics. Our study suggests that the severe hypokalemia in EAST/SeSAME patients 
is not only explained by a downregulation of Na+ transport in the DCT and an 
aldosterone-dependent upregulation of K+ excretion in the CS. The hypokalemia is 
likely related also to a disturbed K+-sensing in the CS that impairs the appropriate 
adaptation of ENaC and ROMK activity to low plasma K+ levels (Fig. 7). Interestingly, 
several single nucleotide polymorphisms (SNPs) that change the biophysical 
properties of Kir4.1 have been described in the KCNJ10 gene45. It is tempting to 
speculate that other unexplained variants of hypokalemia might be linked to 
polymorphisms in Kcnj10 / Kcnj16 or other molecular players involved in the direct 
adaptation of ENaC and ROMK function to altered plasma K+ concentrations.  
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Methods 
Animals 
Mice were maintained at a 12/12 h light/dark cycle with access to standard chow (3430 
Kliba-Nafag, Kaiseraugst, Switzerland) and water ad libitum. Animal experiments were 
conducted according to Swiss Laws and approved by the veterinary administration of 
the Canton of Zurich, Switzerland (License numbers: 213/2015, and 135/2018). For 
each experimental series, animals with matching weight, sex and age were used. CS-
Kcnj10-KO mice were generated by cross-breeding Kir4.1f/f (Jackson Laboratories 
Stock No: 026826)46 with the CS-specific Cre mouse line Aquaporin 2 (AQP2)-Cre47. 
Additionally, mice with the exon 2 of Kcnj1 (ROMK) flanked by loxP sites were custom-
generated by OZgene (Bentley DC, WA 6983, Australia) (Supplementary Fig. 2). The 
CS-Kcnj10-ROMK-KO mouse line was generated by cross breeding CS-Kcnj10-KO 
mice with Kcnj1f/f mice (Supplementary Fig. 2). Mice CS-Kcnj10-KO and CS-Kcnj10-
ROMK-KO were kept homozygous for the floxed alleles and heterozygous for the 
expression of the cre-recombinase. Littermates carrying only the floxed alleles and not 
expressing the cre recombinase were used as control. 
Diets  
Potassium deficient (Low K+; K+ content < 0.05%, Na+ content 0.22%) and the 
correspondent control diet (ctrl K+; K+ content = 0.97%, Na+ content 0.21%) were 
purchased from Ssniff Spezialdiaeten (Soest, Germany Cat No: E15450-20 and 
E15000-00 respectively). For the high K+ diet described in Fig. 4B, 100g of standard 
chow (3430 Kliba-Nafag, Kaiseraugst, Switzerland) with a K+ content of 0.78% (Na+ 
content 0.2 %) was minced and mixed with 4.2g of KCl to obtain a K+ content of 3% 
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(High K+ diet). The powdered food was given as a paste by mixing the same amount 
(weight : weight) of powdered food and water. As control, the same preparation without 
KCl addition was used. 
Metabolic cages studies 
Mice were adapted to metabolic cages (Techniplast, Buguggiate, Varese, Italy) for two 
days on control diet. Afterwards, the diet was changed to either low K+ or high K+ 
during 3 days. 24h urine was collected and frozen. After 3 days with the experimental 
diet, animals were sacrificed by terminal exsanguination via the abdominal vena cava 
and blood and kidney samples were collected. Urine ion analysis was performed by 
flame photometry (Eppendorf, EFOX 5053, Burladingen, Germany). Urinary creatinine 
was quantified using the Jaffe method48.  
Antibodies 
We used previously generated and described antibodies against (dilution used for 
immunoblots (IB) and Immunofluorescence (IF) are indicated in parenthesis) tNCC11 
(IB: 1:2500, IF: 1:10000), pT53NCC11 (IB: 1:2500), -ENaC11 (IB: 1:5000, IF: 
1:20000), -ENaC49 (IB: 1:10000), -ENaC49 (IB: 1:10000) and AQP249 (IB: 1:20000, 
IF 1:200000) . The antibody against Kir4.1 was from Alomone Laboratories (Jerusalem, 
Israel, Cat No: APC-035) (IF: 1:10000). The antibody against -actin was from Sigma 
Aldrich (Sigma, Buchs, Switzerland Cat. No: A5316) (IB: 1:5000). The antibody against 
Na/K-ATPase was a kind gift from Dr. Eric Féraille50 (IB: 1:10000). A novel rabbit anti-
ROMK antibody was generated as described in the supplement and used for IB and 
IF at dilutions of 1: 2000 and 1: 12000, respectively. 
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Hydrochlorothiazide treatment 
Mice were adapted to metabolic cages for 2 days under control diet (3430 Kliba-Nafag, 
Kaiseraugst, Switzerland) minced and mixed with water (weight : weight). On the third 
day, the diet was mixed with hydrochlorothiazide (HCTZ) (Sigma, Buchs, Switzerland. 
Cat. No: H4759) to achieve 40mg of HCTZ /kg of body weight ingested per day. The 
treatment had a duration of three days. The amount of HCTZ added to the food was 
calculated each day taking into account the average food intake of the previous day. 
There were no differences in food ingestion between genotypes.  
Amiloride test 
Mice were adapted to metabolic cages as previously described and received a low K+ 
diet during two consecutive days. Base line urine samples were collected in the 
morning after the second experimental day. Afterwards, each mouse received a single 
intraperitoneal dose of 5 g of amiloride / gram of body weight. Amiloride (Alomone 
Laboratories, Jerusalem, Israel, Cat No: A-140) was diluted in 0.9% sterile NaCl 
solution in a final concentration of 0.5 mg/mL. Each animal received 10 L of this 
solution per gram of body weight. Animals were kept in the metabolic cages for the 
next 4 hours and the urine corresponding to this time was collected and analyzed. 
Blood sample collection and analysis 
Blood samples were collected under Isoflurane anesthesia (Attane, Piramal, India) 
from the inferior vena cava. Blood analysis was immediately performed using the 
Blood Gas analyzer (ABL80 FLEX, Radiometer, Denmark). The remaining blood was 
centrifuged and the plasma was frozen for further analysis. Plasma aldosterone levels 
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were measured using a commercially available Aldosterone ELISA Kit (Caymann 
Chemical, USA) and following the manufacturer instructions. 
Kidney slices and Immunoblotting 
Kidney slice preparation and immunoblotting were previously described elsewhere12. 
In all immunoblots presented in this manuscript, both control and experimental groups 
were run on the same gel. The dashed line in Figs. 1D and 5A were included to help 
readers to easily identify the bands belonging to each group, but do not indicate that 
the samples were run on separate gels. For the densitometric analysis included in 
Figs. 1 and 5 the bands were first normalized to the loading control (-actin) and then 
to the average of control group.  
Immunofluorescence (IF) and IF quantification 
Immunofluorescence (IF) and IF quantification was performed as described in the 
supplement.  
Statistics  
Unpaired student’s t-test was used to compare between two groups. Shapiro-Wilk 
normality test was used to analyze the normal distribution of the samples. For multiple 
comparison, one-way ANOVA or two-way ANOVA with Tukey multiple comparison 
post-test were performed using the software GraphPad Prism 8 (GraphPad Software, 
San Diego, California, USA). 
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Figure 1: Characterization of CS-Kcnj10-KO mice under standard conditions. A: 
Representative immunofluorescence staining of consecutive sections of kidneys from 
control and CS-Kcnj10-KOmice. Sections were stained with the DCT marker NCC 
(labelled with a D in the middle image), Kir4.1 and the CS marker AQP2 (labeled with 
a star in the middle image). Scale bar 50 m B: Quantification of immunofluorescence 
staining of Kir4.1 in sections from control (n=6) and CS-Kcnj10-KO (n=5) mice. In red, 
the mean fluorescence intensity of proximal tubules (negative for Kir4.1) is represented. 
C: Quantification of renin gene expression by qRT-PCR (left graph) and plasma 
aldosterone concentrations (right graph) in CS-Kcnj10-KO and control mice (n=5 mice 
per genotype). Horizontal lines represent the mean of each group. D: Immunoblot of 
the main channels and transporters expressed in the distal nephron of CS-Kcnj10-KO 
and control mice. Molecular weights indicated on the right in kDa. E: Densitometric 
analysis of immunoblots in D normalized to control (in red). In the whole figure 
statistical differences assessed by unpaired Student’s t-test (ns non-significant; *** 
p<0.001).  
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Figure 2: Potassium sensitivity of DCT in control and CS-Kcnj10-KO mice A: 
Representative immunoblot showing changes in NCC phosphorylation at Thr 53 in 
response to changes in extracellular K+ in kidney slices from control (upper panel) and 
CS-Kcnj10-KO mice (lower panel). Molecular weights indicated on the right in kDa B: 
Densitometric quantification of experimental series in A (n=6-9 slices from 3 mice per 
genotype). **p<0.01 assessed by unpaired Student’s t-test). Mean ± SEM is 
represented In B. 
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Figure 3: Response of control and CS-Kcnj10-KO mice to treatment with 
hydrochlorothiazide (HCTZ) during three days (d1-d3) in metabolic cages. A: Urinary 
excretion of K+ (upper graph), Na+ (middle graph) normalized to creatinine and K+/Na+ 
ratio (lower graph) in CS-Kcnj10-KO mice treated with HCTZ. B: Same data as in A 
but normalized to control baseline (d0). *p<0.05; **p<0.01; ***p<0.001 assessed by 
unpaired Student’s t-test. n=6 mice per genotype. In all graphs mean ± SEM is 
represented. 
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Figure 4: Response of control and CS-Kcnj10-KO mice to changes in dietary K+. A: 
Urinary excretion of K+ and Na+ normalized to creatinine of control and CS-Kcnj10-KO 
mice subjected to low K+ (LK) diet during three days in metabolic cages (n=6 mice per 
genotype). B: Urinary excretion of K+ and Na+ normalized to creatinine of control and 
CS-Kcnj10-KO mice subjected to high K+ (HK) diet during three days in metabolic 
cages (n=6 per genotype). Statistical differences in all experiments were assessed by 
unpaired Student’s t-test *p<0.05; **p<0.01; ***p<0.001. mean ± SEM is represented 
in graphs.  
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Figure 5: Characterization of control and CS-Kcnj10-KO mice on dietary K+ 
deprivation. A: Immunoblot of the main ion channels and transporters expressed in 
the distal nephron of control and CS-Kcnj10-KO mice. (molecular weights indicated on 
the right in kDa) B: Densitometric analysis of immunoblots in A normalized to control 
(in red). C: Representative immunofluorescence staining of CSs from control and CS-
Kcnj10-KO mice after three days on low K+ diet. Consecutive sections were stained 
with ENaC (upper panel) and AQP2 antibodies (lower panel). Specific signal in red 
and background autofluorescence in green. D: Effect of a single i.p. dose of amiloride 
on urinary K+ and Na+ in control (n=6) and CS-Kcnj10-KO (n=5) mice after two days 
of dietary K+ deprivation. Statistical differences assessed by two-way ANOVA with 
Tukey multiple comparison post-test (ns non-significant; *p<0.05, ***p<0.001).  
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Figure 6: Abundance of ROMK in control and CS-Kcnj10-KO mice and 
characterization of CS-Kcnj10-ROMK-KO mice. A: Representative 
immunofluorescent stainings in kidneys from control and CS-Kcnj10-KO mice after 
three days on low K+ diet. Consecutive sections were stained with ROMK (upper 
panel) and AQP2 antibodies (lower panel). Specific signal in red and background 
autofluorescence in green. In the graph, the quantification of the staining intensity for 
ROMK across CS cells (basal – apical) from control (n=6) and CS-Kcnj10-KO (n=5) 
mice is represented. B: Concentration of K+ in the plasma of control (n=9), CS-Kcnj10-
KO (n=11) and CS-Kcnj10-ROMK-KO (n=8) mice after three days of dietary K+ 
deprivation. Statistical differences assessed by one-way ANOVA with Tukey multiple 
comparison post-test (ns non-significant; **p<0.01). The data were averaged and are 
presented in Table 5. C: Effect of a single i.p. dose of amiloride on urinary K+ and Na+ 
in control and CS-Kcnj10-ROMK-KO mice after two days of dietary K+ deprivation. n=9 
mice per genotype. Statistical differences assessed by two-way ANOVA with Tukey 
multiple comparison post-test (ns non-significant; *p<0.05, **p<0.01).  
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Figure 7: Proposed model of the function of Kir4.1 in the distal nephron in control 
conditions and in EAST/SeSAME syndrome.   
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Table 1: Effect of Kcnj10 deletion in the collecting system 
on plasma parameters in mice under standard diet 
Parameter       control CS-Kcnj10-KO 
Na+  (mmol/L) 147.0 ± 1.6 146.4 ± 1.2 
K+ (mmol/L) 3.4 ± 0.1 3.2 ± 0.1 
Ca2+ (mmol/L) 0.9 ± 0.1 0.8 ± 0.1 
Cl- (mmol/L) 115.2 ± 2.1 113.6 ± 1.2 
pH  7.3 ± 0.01 7.4 ± 0.02 
HCO3- (mmol/L) 16.5 ± 0.4 16.6 ± 0.5 
Hematocrit (%) 39.6 ± 1.2 39.0 ± 0.9 
   
n=5 mice / group 
 
Table 2: Effect of Kcnj10 deletion in the CS on plasma 
parameters upon three days treatment with HCTZ 
Parameter control CS-Kcnj10-KO 
Na+  (mmol/L) 149.2 ± 0.5 145.2 ± 0.9b 
K+ (mmol/L) 3.7 ± 0.2 3.0 ± 0.1a 
Ca2+ (mmol/L) 1.09 ± 0.05 0.94 ± 0.07 
Cl- (mmol/L) 105.2 ± 0.7 98.8 ± 0.7d 
pH  7.37 ± 0.01 7.47 ± 0.01d 
HCO3- (mmol/L) 19.9 ± 0.4 24.6 ± 0.4d 
Hematocrit (%) 45.3 ± 0.6 47.8 ± 1.4 
ap<0.05; bp<0.01; dp<0.0001 assessed by unpaired 
Student's t test. n=6 mice / group.  
 
Table 3: Effect of Kcnj10 deletion in the CS on plasma 
parameters in mice under low K+ diet 
Parameter        control   CS-Kcnj10-KO 
Na+  (mmol/L) 151.0 ± 0.6 147.8 ± 1.4 
K+ (mmol/L) 3.1 ± 0.2 1.9 ± 0.1c 
Ca2+ (mmol/L) 1.12 ± 0.06 0.99 ± 0.07 
Cl- (mmol/L) 113.6 ± 0.7 105.5 ± 1.2c 
pH  7.31 ± 0.02 7.33 ± 0.02 
HCO3- (mmol/L) 18.2 ± 0.7 21.5 ± 0.9a 
Hematocrit (%) 43.2 ± 0.6 43.5 ± 0.7 
ap<0.05; cp<0.001 assessed by unpaired Student's t test. n=6 mice / group.  
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Table 4: Effect of Kcnj10 deletion in the CS on plasma 
parameters in mice under high K+ diet 
Parameter control CS-Kcnj10-KO 
Na+  (mmol/L) 150.0 ± 1.0 150.0 ± 1.2 
K+ (mmol/L) 4.4 ± 0.2 4.1 ± 0.2 
Ca2+ (mmol/L) 1.02 ± 0.07 0.98 ± 0.08 
Cl- (mmol/L) 113.3 ± 1.1 111.0 ± 1.1 
pH  7.31 ± 0.02 7.34 ± 0.02 
HCO3- (mmol/L) 18.4 ± 0.6 20.0 ± 0.5 
Hematocrit (%) 44.8 ± 0.7 43.8 ± 0.9 
n=6 mice / group.  
Table 5: Effect of Kcnj10 and Kcnj1 deletion in the CS on 
plasma parameters in mice under low K+ diet 
Parameter control (9) CS-Kcnj10-KO (11) CS-Kcnj10-ROMK-KO (8) 
Na+ (mmol/L) 151.2 ± 1.1 147.5 ± 1.2a 149.0 ± 0.5 
K+ (mmol/L) 2.6 ± 0.1 1.6 ± 0.1d 2.3 ± 0.1**** 
Ca2+ (mmol/L) 1.16 ± 0.06 1.14 ± 0.06 1.01 ± 0.05 
Cl- (mmol/L) 110.2 ± 1.0 102.9 ± 1.6c 106.1 ± 0.5 
pH  7.26 ± 0.02 7.33 ± 0.02a 7.37 ± 0.02c 
HCO3- (mmol/L) 17.1 ± 0.5 20.9 ± 0.7c 21.1 ± 0.6c 
Hematocrit (%) 46.6 ± 1.0 43.0 ± 1.0a 39.5 ± 0.9c* 
ap<0.05; bp<0.01; cp<0.001; dp<0.0001; compared to control group assessed by one-way 
ANOVA with Tukey’s multiple comparison post-test. *p<0.05; ****p<0.0001 compared to CS-
Kcnj10-KO group assessed by one-way ANOVA with Tukey’s multiple comparison post-test. 
Number of animals per group in parenthesis (n).  
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ROMK antibody 
A novel rabbit anti-ROMK antibody recognizing the C-terminal region of ROMK was 
custom made by Pineda Antikörper-Service (Berlin, Germany). After immunization of 
rabbits against the peptide NH2-CDNPNFVLSEVDETDDTQM-CCOH, the obtained 
antisera were affinity-purified against the immunizing peptide. As shown in 
Supplementary Fig. 3, the antibody shows a similar banding pattern on immunoblots of 
mouse kidneys as previously observed by Wade and co-workers1 using a different anti-
ROMK antibody (IB: 1: 2000). Moreover, immunostaining of kidney from CS-Kcnj10-
ROMK-KO confirmed the specificity of the ROMK antibody (IF: 1: 12000). While a strong 
ROMK-related immunostaining was seen in non-targeted DCT cells, no 
immunofluorescent signal was seen in connecting tubules and collecting ducts, in which 
ROMK was deleted (Supplementary Fig. 2). 
Sample preparation for quantitative qPCR 
Kidneys were removed and immediately transferred into RNA lysis buffer and 
homogenized using Percellys Tissue Homogenizer (Bertin Technologies SAS, Montigny-
le-Bretonneux, France). RNA was isolated using the NucleoSpin® kit (Macherey-Nagel 
GmbH, Düren, Germany) as per the manufacturer`s protocol. 1 μg of total RNA was used 
to generate cDNA using the kit GoScript Reverse Transcription System (Promega AG, 
Dübendorf, Switzerland) as per the protocol. The cDNA was diluted 1:5 with nuclease-
free water for qRT-PCR. 
Primers 
The following primers were used for quantitative PCR (qPCR) and genotyping: 
Primer name Sequence Use 
Kcnj10 flox 
Fwd: ATCTCGATTGCTGCTTGAGA 
Bckwd: TTTTGCCCTACTCAATGCTCT 
Genotyping Aqp2Cre 
Fwd1: AAGTGCCCACAGTCTAGCCTCT 
Fwd2: CCTGTTGTTCAGCTTGCACCAG 
Bckwd: GGAGAACGCTATGGACCGGAGT 
ROMK flox 
Fwd: GTGCCATGTGCCTCTATAATGAGA 
Bckwd: TCTTCTAGAATCATAGCCATGGGG 
renin 
Fwd: GGAGGAAGTGTTCTCTGTCTACTACA 
Bckwd: GCTACCTCCTAGCACCACCTC 
qPCR 
-actin 
Fwd: CCACCGATCCACACAGAGTACTT 
Bckwd: GACAGGATGCAGAAGGAGATTACTG 
 
 
Immunofluorescence (IF) and IF quantification 
For IF quantification, images were acquired using a spinning disc confocal microscope 
(Olympus IX83) equipped with a 30X UPLSAPO UPlan S Apo silicon oil immersion 
objective. To this end, 6 control and 5 CS-Kcnj10-KO mice were subjected to dietary K+ 
deprivation for 3 days and perfused with 3% PFA. Consecutive cryosections of perfusion-
fixed kidneys were stained with rabbit polyclonal antibodies against NCC (labeling the 
DCT) and / or AQP2 (labeling CNT and CD) and one of the proteins of interest (i.e. 
ENaC, ROMK, or Kir4.1). Sections were then imaged at a confocal microscope by an 
investigator blinded for the genotype of the analyzed mice. Subsequently, obtained 
images were independently analyzed by two investigators without knowledge of the 
genotype of the mice. Both investigators came to the same conclusions regarding the 
expression levels and the subcellular localization of the studied proteins in the respective 
mice. To confirm the qualitative judgements of the two investigators, ROMK and Kir4.1, 
staining intensities were also quantified using imaging software (see below). 
For the quantification of Kir4.1, three cryosections per animal (6 control mice and 5 CS-
Kcnj10-KO mice) were imaged and the mean fluorescence intensity was measured in 5 
proximal tubule (PTs), 10 DCTs and 10 CS per section as depicted in supplementary Fig. 
4A using the ImageJ software. The mean fluorescence intensity of each structure was 
normalized to the mean intensity of all PTs of the same section to obtain its relative 
fluorescence intensity (RFI) per section. The RFI obtained for each section was then 
again averaged to serve as average value for each animal data to calculate the mean 
values for each of the two animal groups. 
For the quantification of ROMK, the axial fluorescence intensity (basal to apical) was 
measured in 5 proximal tubule (PTs) cells and 10 CS cells as depicted in supplementary 
Fig. 4B using the ImageJ software and the provided supplementary macro. The axial 
fluorescence intensity of each CS cell was normalized to the mean axial intensity of the 
PTs of the same section to obtain the CS relative axial fluorescence intensity (CS-RAFI) 
of this cell. All 10 CS-RAFI from each image were averaged to obtain the section CS-
RAFI, while section CS-RAFI obtained from each animal were averaged to obtain the CS-
RAFI corresponding to each animal. Finally, the CS-RAFI corresponding to 6 control 
animals and 5 CS-Kcnj10-KO mice are represented in Figure 6 as mean ± SEM. 
 
Supplementary Figure 1: Correlation of NCC phosphorylation with plasma 
K+ concentration in control (n=20) and CS-Kcnj10-KO (n=25) mice. 
  
 
Supplementary Figure 2: Characterization of CS-Kcnj10-ROMK-KO mouse 
model. A: Scheme of genetic modification of Kcnj1flox/flox mice before and after cre-
mediated recombination. B: Genotyping of Kcnj1flox/flox mice. C: Immunofluorescence 
staining of AQP2 and ROMK in consecutive sections from kidneys of control and CS-
Kcnj10-ROMK-KO mice. DCTs are labeled with a D while CSs are labelled with a star. 
Transitions DCT-CNT are marked with arrowheads. Scale bar 50 m. 
  
 
Supplementary Figure 3: Characterization of novel rabbit anti-ROMK 
antibody using lysates of total kidneys of control mice. Bands were identified and labelled 
according to Wade et al1. 
  
 
Supplementary Figure 4: Examples of Immunofluorescence quantification. 
A: Quantification of fluorescence intensity of ROMK staining across cells (basal – apical) 
in cells of the PT (1), CS (2) and TAL (3). In the graph, the relative fluorescence intensity 
is normalized to PT fluorescence. B: Quantification of average fluorescence intensity of 
Kir4.1 staining in a PT (1) CS (2) and DCT (3). 
  
Supplementary Table 1: Effect of Kcnj10 and 
ROMK deletion in the collecting system on plasma 
parameters in mice under standard diet. 
   
Parameter control CS-Kcnj10-ROMK-KO 
Na+  (mmol/L) 148.0 ± 0.3 148.8 ± 0.8 
K+ (mmol/L) 3.3 ± 0.1 3.2 ± 0.2 
Ca2+ (mmol/L) 1.0 ± 0.04 1.1 ± 0.03a 
Cl- (mmol/L) 108.7 ± 0.8 109.4 ± 1.3 
pH 7.2 ± 0.02 7.3 ± 0.03 
HCO3- (mmol/L) 17.4 ± 0.5 18.3 ± 0.6 
Hematocrit (%) 43.2 ± 1.1 42.0 ± 1.9 
   
ap<0.05 assessed by unpaired Student's t test. n=5 mice / group. 
  
Supplementary Macro 
/* 
* Normalizes line profiles by making use of the Straighten command followed by 
scaling 
* By Olivier Burri, BioImaging And Optics Platform 
* In Response to 
http://forum.imagej.net/t/average-pixels-with-line-tool/6408?u=oburri 
* Modified by Joana R. Martins, Center of Microscopy and Image Analysis, 
University of Zurich 
* OUTPUT is the values of the line profile as a results table 
* Column name is the image name. 
* the number of rows corresponds to the normalization length normLength 
*/ 
//setBatchMode(true); 
normLength = 200; //px the final length you want 
lineWidth = 10; // Line thickness to average intensities along the perpendicular 
axis 
imageName = getTitle(); 
print("image name is "+imageName); 
nROIs = roiManager("count"); 
print(nROIs); 
for (j = 0; j < nROIs ; j++) { 
selectWindow(imageName); 
roiManager("select", j); 
print("loop" + j); 
run("Straighten...", "title=SubImage line="+lineWidth); 
run("Scale...", "x=- y=- width="+normLength+" height="+lineWidth+" 
interpolation=Bilinear create"); 
run("Line Width...", "line="+lineWidth); 
makeLine(0,lineWidth/2, normLength, lineWidth/2); 
data = getProfile(); 
for(i=0; i<normLength; i++) { 
setResult(j, i, data[i]); 
} 
close(); 
close(); 
} 
//setBatchMode(false); 
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